Infliximab Therapeutic Mixture from Canada
Mixed immunological preparation containing infliximab monoclonal antibodies for autoimmune diseases like Crohn's. HTS 3002.14.0010 for bulk mixed monoclonal products used in biotech manufacturing. Includes polysorbate and histidine buffers.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Provide immunogenic profile data; monitor for anti-drug antibody formation risks
• Use validated shipping containers for biologics; include stability data at import temps
• Confirm not a 'simple vegetable extract' per chapter note 3 to maintain classification